Skip to main content
Intermediate Technical In the Industry Vocabulary Test

inotropic support

Pronunciation: in-oh-TROP-ik suh-PORT

Pharmacological support using medications that increase myocardial contractility to improve cardiac output in patients with heart failure.

Full Definition

Inotropic support refers to the use of medications that enhance myocardial contractility to improve cardiac output and hemodynamic stability, particularly in patients with heart failure or low cardiac output states. Common inotropic agents include dobutamine, dopamine, epinephrine, and milrinone, each with different mechanisms of action and hemodynamic profiles. This support is frequently required during cardiac surgery, especially after cardiopulmonary bypass when myocardial dysfunction may occur. The choice of inotropic agent depends on the specific hemodynamic goals and patient condition. Medical editors should distinguish between positive inotropic effects (increased contractility) and chronotropic effects (increased heart rate).

Usage

Usage note: Distinguish from vasopressor support, which primarily affects vascular tone rather than contractility.

In Context

  • "The patient required high-dose inotropic support to maintain adequate cardiac output following valve replacement surgery." — clinical note
  • "Weaning from inotropic support was achieved gradually over the first postoperative day." — progress note

Also known as

inotropic therapy positive inotropic support

Contrasted with

negative inotropic therapy

Don't confuse with

chronotropic support vasopressor support

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON